NCT06401785 To Evaluate the Efficacy of Oral Molecular Hydrogen Supplement in Patients With Chronic Diseases
| NCT ID | NCT06401785 |
| Status | Recruiting |
| Phase | Phase 2 |
| Sponsor | HoHo Biotech |
| Condition | Chronic Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-05-11 |
| Primary Completion | 2024-12-29 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The supplementation of hydrogen molecules as an aid, adjuvant, may speed up recovering the course of the disease. The purpose of this study is to determine the possible efficacy and safety of solid hydrogen supplements for a clinical study in patients with chronic diseases. Patients will receive hydrogen capsules with their conventional treatment for 24 weeks. Investigators will test for any changes in haematologic, urine analysis and health status during and following the exposure period.
Eligibility Criteria
Inclusion Criteria: * Age 20 to 80 * Able to compliant with the protocol * Able to return to the hospital regularly * Patients with chronic inflammation, including patients with autoimmune diseases, metabolic-related diseases, chronic kidney disease or nephritis, tumor patients, etc. Exclusion Criteria: * Pregnancy * Expected pregnancy * Attending other clinical trials with 6 months